Treatment News : Findings on 'Broadly Neutralizing Antibodies' May Be Key to HIV Vaccine

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » April 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

April 4, 2013

Findings on 'Broadly Neutralizing Antibodies' May Be Key to HIV Vaccine

For the first time, scientists have mapped the coevolution of HIV and the corresponding immune response in a single person, providing vital clues that may help in the development of a vaccine, The New York Times reports. Publishing their findings in the online edition of the journal Nature, scientists sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) analyzed weekly blood samples from one African man beginning four weeks after he was infected and continuing for more than three years.  

The investigators were able to chart the virus as it evolved and eventually prompted the man’s immune system to produce what are known as “broadly neutralizing antibodies,” which in his case were able to counteract up to some 55 percent of HIV strains found around the world.

Over the past few years, researchers have made increasing strides in understanding the function and development of these antibodies, which block the receptors HIV uses to latch onto human cells before infecting them. About one in five people with HIV will eventually produce broadly neutralizing antibodies, but they will largely do so too late: after the viral population has mutated enough to evade the antibodies’ effects. Now that scientists better understand this evolution, the hope is to develop a vaccine that could harmlessly imitate the virus at pivotal steps in the process and prompt the body to produce these antibodies on its own, which counteract a new infection.

To read the New York Times report, click here.

To read the NIH release, click here.

Search: HIV, vaccine, broadly neutralizing antibodies, The New York Times, National Institute of Allergy and Infectious Diseases, NIAID, coevolution.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (1 total)

 
[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Starting Treatment
Search for the Cure
POZ Stories
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar


    dave41
    Bethany
    Oklahoma


    usuallyhappy
    Palm Springs
    California


    Sexynyrican
    Brooklyn
    New York


    blaze11212
    brooklyn
    New York
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Do you enjoy books with HIV-positive characters?
Yes
No

Survey
Mind Matters

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.